Disorders of Sex Development (DSD) are medical conditions in which the development of chromosomal, gonadal, or anatomical sex is atypical. These variations occur when there is a disruption in the usual process of sexual differentiation—a complex sequence that begins at approximately 7 to 8 weeks of fetal development and is typically complete by the 12th week of gestation.
Previously referred to as intersex, the term DSD was formally introduced in 2006 during the International Consensus Conference led by leading pediatric endocrinology societies. This terminology was adopted to reduce the stigma associated with older labels and to ensure a more respectful and clinical approach to care.
Human beings have 46 chromosomes in every cell—23 from the mother and 23 from the father. Among these, two are sex chromosomes:
Females: 46,XX
Males: 46,XY
The Y chromosome contains the SRY gene, a crucial element that signals the development of male characteristics. Under this influence:
Testes begin to form in males.
Testes secrete two essential hormones:
Müllerian Inhibiting Substance (MIS): suppresses female reproductive organ development.
Testosterone: promotes male reproductive structures.
Testosterone is later converted into Dihydrotestosterone (DHT)—a more potent form—which helps in forming external male genitalia. In females, who lack the Y chromosome and the SRY gene, the default pathway leads to ovarian development and female genital formation.
When there's a disruption in this biological pathway, DSD may result.
Ambiguous genitalia
Micropenis or severe hypospadias with undescended testes
Clitoral enlargement
Labial fusion
Inguinal hernia in female infants
Delayed or incomplete puberty
Primary amenorrhea (no menstruation)
Infertility
Male breast development (gynecomastia)
Cyclical hematuria (blood in urine during menstruation in a genetically male child)
The current classification system, as recommended by international pediatric endocrine societies, includes:
Disorders of testicular development: e.g., Swyer syndrome, gonadal dysgenesis
Disorders of androgen synthesis: e.g., 17-OH steroid dehydrogenase deficiency, 5α-reductase deficiency
Androgen insensitivity syndromes: partial or complete
Leydig cell aplasia
Persistent Müllerian duct syndrome
Disorders of ovarian development
Excess androgen exposure, including:
Congenital Adrenal Hyperplasia (CAH)
Aromatase deficiency
Maternal hormone-producing tumors (e.g., luteoma)
Ovotesticular DSD: presence of both ovarian and testicular tissue
46,XX testicular DSD: previously termed XX male syndrome
46,XY complete gonadal dysgenesis: previously known as XY sex reversal
Klinefelter Syndrome (47,XXY)
Turner Syndrome (45,XO)
Proper diagnosis begins with a detailed clinical examination. Based on findings, targeted investigations are carried out, including:
Ultrasound imaging (to detect internal organs like uterus or gonads)
Karyotyping (chromosomal analysis)
Hormonal assays: Testosterone, DHT, LH, FSH, Estradiol
17-Hydroxyprogesterone levels
MRI pelvis (in some cases)
Retrograde genitogram (to assess urogenital anatomy)
Adrenal steroid profiling
Your healthcare provider will determine which tests are most suitable based on the suspected DSD subtype.
Treatment of DSD is multidisciplinary and includes:
Early psychological and emotional support for families is critical. Parents are educated about the condition and options available for treatment.
In cases where genital ambiguity is present, a decision is made regarding gender assignment based on genetic, hormonal, anatomical, and future fertility factors.
Reconstructive surgery may be performed to align external genitalia with the chosen gender. This could involve:
Genital reconstruction
Gonadectomy (in case of increased cancer risk)
Urogenital sinus correction
Note: Surgical intervention is highly individualized and usually delayed until thorough assessments are complete.
In some cases, hormone replacement therapy (HRT) is necessary to ensure the development of secondary sexual characteristics during puberty.
Long-term psychological care helps the child and family adjust and cope. This support continues into adolescence and adulthood.
The International Hypospadias Foundation (IHF) is a pioneering, multidisciplinary initiative dedicated to the comprehensive management of hypospadias. From diagnosis to surgery, psychological support, and long-term rehabilitation—we provide a complete and compassionate continuum of care.
© 2025 International Hypospadias Foundation. All Rights Reserved. Designed, Developed & Maintained by Brand Brilliance